Dr. Gross on the Prognosis of Cutaneous Squamous Cell Carcinoma of the Head and Neck

Video

In Partnership With:

Neil D. Gross, MD, FACS, discusses the prognosis of patients who are diagnosed with cutaneous squamous cell carcinoma of the head and neck.

Neil D. Gross, MD, FACS, professor and director of Clinical Research, Department of Head and Neck Surgery, Division of Surgery, at The University of Texas MD Anderson Cancer Center, discusses the prognosis of patients who are diagnosed with cutaneous squamous cell carcinoma of the head and neck.

Head and neck cancer encompasses a broad range of cancers that can develop in the mouth, thyroid, skin, salivary glands, and sinuses, says Gross. Each subtype has a different prognosis, he adds. Cutaneous squamous cell carcinoma is one such subset that has been understudied. The primary reason for this is that skin cancers aside from melanoma are too common to account for in national registries.

Early-stage cutaneous squamous cell carcinoma is typically treated in the community setting. Once the disease progresses to an advanced stage, patients are referred to centers of excellence due to the aggressive nature of the disease, concludes Gross.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Michael Leung, PharmD, an expert on colorectal cancer
A panel of 4 experts on colorectal cancer